Prophylactic therapy in children with hereditary angioedema - 30/01/13
Supported by the OTKA-NKTH 100886 grant (to H.F.). |
|
Disclosure of potential conflict of interest: H. Farkas has received research support from OTKA-NKTH; has received consultancy fees and travel support from Shire, Pharming, Viropharma, and CSL Behring; and has received lecture fees from Shire. D. Csuka has received travel grants from CSL Behring, Shire, and Viropharma. L. Varga has received travel support from CSL Behring and Shire. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 131 - N° 2
P. 579 - février 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?